The Commerce Department began administrative reviews for certain firms subject to antidumping and countervailing duty orders with September anniversary dates. The agency said it intends to issue the final results of these reviews by Sept. 30, 2014.

The International Trade Commission published notices in the Nov. 6 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):

The International Trade Commission is ending its Section 337 investigation on interactive program guide and parental control technology, affirming an administrative law judge’s finding of no violation of Section 337 by Netflix and Roku. The ITC affirmed the ALJ’s finding that violative products were actually being imported, and that its patents weren’t being infringed in any case. The investigation, which began in June 2012, covered televisions, media players, and software applications that include interactive programs guides or parental control technology in a specified format (see 12053168). It was requested by Rovi Corporation, and originally included LG, Mitsubishi, and Vizio as respondents.

The International Trade Commission is asking for comments by Nov. 14 on public interest factors raised by BTG International’s Section 337 patent complaint on snake antivenom that purportedly infringes its patents. BTG filed its complaint on Oct. 30, alleging that three U.S. companies and four Mexican companies are importing and selling an antivenom used to treat snake bites from pit viper snakes such as rattlesnakes. The antivenom imports infringe a patent held by BTG on a method to prevent serum sickness, a potentially life-threatening immune reaction, it said. BTG is requesting limited exclusion orders and cease and desist orders against the import and sale of the allegedly infringing antivenom.

The Commerce Department intends to exempt rectangular wire from antidumping and countervailing duties on aluminum extrusions from China (A-570-967/C-570-968), it said in the preliminary results of a changed circumstances review. The partial revocation was requested by 3M in June, and to date no domestic producers have expressed any interest in maintaining AD/CVD coverage on rectangular wire, despite Commerce’s request for comments in August (see 13081921). If in the final results Commerce continues to find rectangular wire should be exempted from AD/CV duties, it will add the following exclusion paragraph to the scope of the AD/CV duty orders on aluminum extrusions from China:

Importers of plywood from China won’t face antidumping and countervailing duties, after the International Trade Commission voted on Nov. 5 that imports of hardwood and decorative plywood from China aren’t injuring domestic industry. The ITC’s unanimous vote means the Commerce Department will not put AD and CV duty orders on hardwood plywood from China. Commerce was set to impose AD duties of 55.76% to 121.65%, and CV duties of up to 27.16%, on Chinese plywood imports (see 13050216 and 13092028). Commerce will now end its investigation, and order CBP to refund cash deposits it had been collecting since March.

The International Trade Commission published notices in the Nov. 5 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):

The Commerce Department published notices in the Nov. 5 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):

BTG International is asking the International Trade Commission to ban imports of snake antivenom that allegedly infringe its patents, in violation of Section 337. BTG says three U.S. companies and four Mexican companies are importing and selling an antivenom used to treat snake bites from pit viper snakes such as rattlesnakes. The antivenom imports infringe a patent held by BTG on a method to prevent serum sickness, a potentially life-threatening immune reaction. BTG says the antivenom imports, which are marketed as “Antivipmyn,” “Anavip,” and generic names like “Antivenin-Bothrops asper and Crotalus durissus,” threaten the domestic industry BTG has developed through its FDA-approved drug CroFab Crotalidae Polyvalent Immune Fab (Ovine). BTG is requesting cease and desist orders and limited exclusion orders banning import and sale of the infringing antivenom.

The Commerce Department published notices in the Nov. 4 Federal Register on the following AD/CV duty proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):